Tirzepatide for diabetic nerve damage in the feet and legs
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study tests a new medicine called tirzepatide to see if it can improve nerve damage in the feet and legs caused by diabetes. It may be a good option for people with diabetes who also struggle with weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have had diabetes for less than 10 years.
- Your HbA1c (average blood sugar) is between 7% and 10%.
- You have symptoms of nerve damage in your feet or legs, like numbness, tingling, or pain.
- Your body mass index (BMI) is 27 or higher.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tirzepatide, a medicine that helps lower blood sugar and manage weight, is safe and effective for people with type 1 diabetes who are overweight or have obesity. You must already use an automated insulin pump system.
This trial studies tirzepatide to see if it can slow the progression of coronary artery plaque in people with type 2 diabetes. It uses special heart CT scans to track changes over time.
This trial tests if tirzepatide, a weekly injection, can help people with type 1 diabetes who are also overweight or obese. The goal is to see if it improves blood sugar control and supports weight loss.
This study tests if the drug tirzepatide can improve muscle and blood vessel health in older adults with obesity. You may be eligible if you are 50 or older, have a BMI between 30 and 40, and do not have diabetes.
This trial tests a once-weekly injection called tirzepatide to see if it helps people with type 2 diabetes and obesity control their blood sugar and lose weight. The goal is to see how well it works and how satisfied patients are with this treatment.
This study tests a medication called tirzepatide for people with type 1 diabetes who also have overweight or obesity. Tirzepatide may help with weight loss and blood sugar control, and you'll use a continuous glucose monitor throughout the study.
Hear when a new Neuropathy, Small Fiber trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.